Showing results (761-770 of 2,229) with videos related to
Sort By:
Pageof 223
Cancer Biotherapy & Radiopharmaceuticals|March 3, 2021
Clinical Evaluation of a Three-Dimensional Internal Dosimetry Technique for Liver Radioembolization with 90Y Microspheres Using Dose Voxel KernelsDimitris Plachouris, Konstantinos A Mountris, Panagiotis Papadimitroulas, et al.Cancer Biotherapy & Radiopharmaceuticals|July 23, 2019
Correction to: Retraction of: Tumor Protein D52-Like 2 Accelerates Gastric Cancer Cell Proliferation; 10..2014.17610.89/cbr6Cancer Biother Radiopharm 2017;32(10):388. DOI: 10.1089/cbr.2014.1766.retractCancer Biotherapy & Radiopharmaceuticals|March 6, 2019
Design, Synthesis, Radiolabeling, and Biologic Evaluation of Three 18F-FDG-Radiolabeled Targeting Peptides for the Imaging of ApoptosisSepideh Khoshbakht, Davood Beiki, Parham Geramifar, et al.Cancer Biotherapy & Radiopharmaceuticals|June 29, 2012
Immunotherapy and targeted therapies in metastatic renal cell carcinoma: is there a preferred sequence?Jacopo Giuliani, Fabrizio DrudiCancer Biotherapy & Radiopharmaceuticals|September 6, 2012
Prediction of therapy tumor-absorbed dose estimates in I-131 radioimmunotherapy using tracer data via a mixed-model fit to time activityMatthew J Schipper, Kenneth F Koral, Anca M Avram, et al.Cancer Biotherapy & Radiopharmaceuticals|October 6, 2012
microRNA-34a sensitizes lung cancer cell lines to DDP treatment independent of p53 statusXi Wang, Ke Dong, Ping Gao, et al.Cancer Biotherapy & Radiopharmaceuticals|October 19, 2012
Radiopharmaceuticals for bone metastasis therapy and beyond: a voyage from the past to the present and a look to the futureSara Ferreira, Irene Dormehl, Maria Filomena BotelhoCancer Biotherapy & Radiopharmaceuticals|July 27, 2012
Synthesis and biological evaluation of a novel (177)Lu-DOTA-[Gly(3)-cyclized(Dap(4), (d)-Phe(7), Asp(10))-Arg(11)]α-MSH(3-13) analogue for melanocortin-1 receptor-positive tumor targetingJae Cheong Lim, Young Don Hong, Jin Ju Kim, et al.Cancer Biotherapy & Radiopharmaceuticals|June 27, 2012
Outpatient intravenous interleukin-2 with famotidine has activity in metastatic melanomaWalter D Y Quan, Francine M Quan, Mia Perez, et al.Cancer Biotherapy & Radiopharmaceuticals|April 8, 2004
Intralesional radioimmunotherapy with Yttrium-90-labeled human monoclonal IgM in nude mice bearing human tumor xenograftsPaul E Borchardt, Huibert M Vriesendorp, Ralph S Freedman, et al.Pageof 223